Emily Leongini to Speak on FDA Regulation at the Marijuana Business Conference
FDA attorney Emily Leongini will be presenting at the Marijuana Business Daily’s Marijuana Business Conference on May, 18, 2017. The session “The Perils of Rescheduling and FDA Regulation” will examine how rescheduling marijuana could cause unintended consequences for the legal cannabis industry. This panel will focus on what cannabis companies might face if their products were regulated by FDA. Emily will be joined by Andrew Perraut of Radiant Strategies, a former OMB official who oversaw rulemaking related to food, tobacco, biotech, and agriculture. The Marijuana Business Conference is the oldest and largest conference in the industry and will feature over 3,500 cannabis business leaders and executives.
Click here to learn more about the conference and to register.